Skip to content

Nuo Therapeutics, Inc.

AURX

CIK 0001091596

← back to feed
Revenue (TTM)
$700.31K
+52.6% YoY Q1 May 2026
Net Income (TTM)
−$2.55M
−8.1% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.08
−111.1% YoY Q1 May 2026
Gross Margin
339.8%
Q1 May 2026
Operating Margin
-340.4%
Q1 May 2026
Net Margin
-364.4%
Q1 May 2026
Free Cash Flow (TTM)
−$2.38M
Q1 May 2026
Cash
$263.83K
Q1 May 2026
Total Debt
$0
Q1 May 2026
Shares Outstanding
48.41M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings